Bayer Settled Baycol Lawsuits. Bayer AG, Germany’s second-largest drug and chemical maker, has agreed to pay $1.06 billion to settle 2,771 lawsuits relating to its withdrawn cholesterol treatment Baycol.
The company has 8,048 cases pending, 515 fewer than a month ago, spokeswoman Annette Josten said. The company had paid out $1.04 billion to settle 2,710 cases as of June 14.
insurance will cover payments
Bayer has said insurance will cover payments up to $1.2 billion, and has set aside an additional 300 million euros ($371 million). The company will continue to examine the need for further risk provision, Chief Executive Officer Werner Wenning said in April.
Bayer withdrew Baycol, a member of the statin class of medicines, in August 2001, after some patients developed muscle weakening and kidney failure. The drug was linked to as many as 100 deaths.
Need Legal Help Regarding Baycol Lawsuits?
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Our Baycol side effects lawyers are here to help you when you need it the most.